Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
COSMOS Pharmaceutical Corporation ( (JP:3349) ) has provided an announcement.
COSMOS Pharmaceutical Corporation reported a significant increase in its financial performance for the fiscal year ended May 31, 2025, with net sales reaching ¥1,011,390 million, a 4.8% increase from the previous year. The company’s operating profit and ordinary profit also saw substantial growth, indicating a strong operational performance. The company’s strategic financial management is reflected in its improved equity ratio and increased cash and cash equivalents, suggesting a positive outlook for stakeholders.
The most recent analyst rating on (JP:3349) stock is a Buy with a Yen9700.00 price target. To see the full list of analyst forecasts on COSMOS Pharmaceutical Corporation stock, see the JP:3349 Stock Forecast page.
More about COSMOS Pharmaceutical Corporation
COSMOS Pharmaceutical Corporation is a company listed on the Tokyo Stock Exchange, operating within the pharmaceutical industry. The company focuses on the production and distribution of pharmaceutical products, serving a market that demands high-quality healthcare solutions.
Average Trading Volume: 368,947
Technical Sentiment Signal: Buy
Current Market Cap: Yen738.1B
See more insights into 3349 stock on TipRanks’ Stock Analysis page.